Comments
Suven Life Sciences Ltd's net profit increased 9.8 per cent at Rs 2.56 crore (Rs 2.33 crore) in the second quarter ended September 30, 2011.
The total revenue of the Hyderabad-based company grew by 31 pc at Rs 49.6 crore (Rs 37.8 crore). The earnings per share stood at Rs 0.22 (Rs 0.20).
During the quarter under review, Suven spent Rs 8.7 crore on research and development for drug discovery, according to a release.
The company's scrip ended at Rs 16.80 on the Bombay Stock Exchange on Tuesday. –
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.